Genpact Limited Stock Performance
| G Stock | USD 43.67 0.77 1.73% |
The company retains a Market Volatility (i.e., Beta) of 0.73, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genpact's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genpact is expected to be smaller as well. At this point, Genpact Limited has a negative expected return of -0.28%. Please make sure to check out Genpact's skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Genpact Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Genpact Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in June 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return (1.73) | Five Day Return 1.13 | Year To Date Return 1.58 | Ten Year Return 91.03 | All Time Return 160.72 |
Forward Dividend Yield 0.0153 | Payout Ratio | Forward Dividend Rate 0.68 | Dividend Date 2025-03-26 | Ex Dividend Date 2025-03-11 |
1 | Disposition of 1400 shares by Laura Conigliaro of Genpact subject to Rule 16b-3 | 03/07/2025 |
2 | Acquisition by Michael Weiner of 14587 shares of Genpact subject to Rule 16b-3 | 03/11/2025 |
3 | Disposition of 13600 shares by Balkrishan Kalra of Genpact at 27.65 subject to Rule 16b-3 | 03/13/2025 |
| Genpact dividend paid on 26th of March 2025 | 03/26/2025 |
4 | Heres Why Genpact is a Strong Growth Stock | 03/31/2025 |
5 | Legal General Group Plc Grows Position in Genpact Limited | 04/16/2025 |
6 | Genpact Q1 2025 Earnings Preview | 05/06/2025 |
7 | Genpact adjusts 2025 revenue guidance amid strong AI traction and deal delays | 05/08/2025 |
8 | Genpact First Quarter 2025 Earnings EPS Beats Expectations | 05/09/2025 |
9 | Genpact Named a Leader in ISG Provider Lens 2025 for ServiceNow | 05/12/2025 |
10 | Acquisition by Gangestad Nicholas C of 2000 shares of Genpact at 43.97 subject to Rule 16b-3 | 05/13/2025 |
11 | Insider Buying Nicholas Gangestad Acquires Shares of Genpact Ltd | 05/15/2025 |
12 | Business Process Outsourcing Consulting Stocks Q1 Recap Benchmarking CBIZ | 05/20/2025 |
| Begin Period Cash Flow | 583.7 M |
Genpact Relative Risk vs. Return Landscape
If you would invest 5,307 in Genpact Limited on February 21, 2025 and sell it today you would lose (940.00) from holding Genpact Limited or give up 17.71% of portfolio value over 90 days. Genpact Limited is generating negative expected returns and assumes 2.5408% volatility on return distribution over the 90 days horizon. Put is differently, 22% of stocks are less volatile than Genpact, and over 99% of all traded equities are expected to make higher returns on investment over the next 90 days. Expected Return |
| Risk |
Genpact Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genpact's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genpact Limited, and traders can use it to determine the average amount a Genpact's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1083
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | G |
Estimated Market Risk
| 2.54 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genpact is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genpact by adding Genpact to a well-diversified portfolio.
Genpact Fundamentals Growth
Genpact Stock prices reflect investors' perceptions of the future prospects and financial health of Genpact, and Genpact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genpact Stock performance.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.0938 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 8.65 B | |||
| Shares Outstanding | 174.87 M | |||
| Price To Earning | 28.59 X | |||
| Price To Book | 3.17 X | |||
| Price To Sales | 1.60 X | |||
| Revenue | 4.77 B | |||
| Gross Profit | 1.72 B | |||
| EBITDA | 843.57 M | |||
| Net Income | 513.67 M | |||
| Cash And Equivalents | 646.76 M | |||
| Cash Per Share | 2.53 X | |||
| Total Debt | 1.45 B | |||
| Debt To Equity | 1.04 % | |||
| Current Ratio | 1.58 X | |||
| Book Value Per Share | 14.04 X | |||
| Cash Flow From Operations | 615.42 M | |||
| Earnings Per Share | 2.94 X | |||
| Market Capitalization | 7.77 B | |||
| Total Asset | 4.99 B | |||
| Retained Earnings | 1.24 B | |||
| Working Capital | 1.12 B | |||
| Current Asset | 1.2 B | |||
| Current Liabilities | 594.48 M | |||
About Genpact Performance
By analyzing Genpact's fundamental ratios, stakeholders can gain valuable insights into Genpact's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genpact has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genpact has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 16.81 | 15.97 | |
| Return On Tangible Assets | 0.16 | 0.10 | |
| Return On Capital Employed | 0.17 | 0.10 | |
| Return On Assets | 0.10 | 0.06 | |
| Return On Equity | 0.21 | 0.13 |
Things to note about Genpact Limited performance evaluation
Checking the ongoing alerts about Genpact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genpact Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genpact Limited generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 26th of March 2025 Genpact paid $ 0.17 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Business Process Outsourcing Consulting Stocks Q1 Recap Benchmarking CBIZ |
- Analyzing Genpact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genpact's stock is overvalued or undervalued compared to its peers.
- Examining Genpact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genpact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genpact's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genpact's stock. These opinions can provide insight into Genpact's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |